40 min ago | KFVS12
For years pediatricians have recommended that girls 14 to 19 get the human papillomavirus vaccine to prevent certain kinds of cancer.
The first study of a controversial vaccine has supporters singing its praises. Gardasil prevents human papillomavirus, a common sexually transmitted disease that causes most cervical cancers.
This is the first evidence of how well the HPV vaccine works since it came on the market seven years ago.
Supporters of a far-reaching immigration bill in the Senate see fresh momentum from a report by the Congressional Budget Office that the measure would boost the economy and reduce federal deficits by billions of... After secretive talks, key senators express optimism they are closing in on a bipartisan agreement to toughen the border security ... (more)
A tongue-in-cheek controversy is threatening to sink the reputation of a beloved cereal icon.
WASHINGTON) -- Vaccines against the cancer-causing human papillomavirus appear to be working better than expected in the U.S. given the country's dismal vaccination rates, according to a new study from the U.S. Centers for Disease Control and Prevention.
The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papillomavirus or HPV - the sexually transmitted virus that causes the disease - by more than half among girls and young women, U.S. health officials said on Wednesday.
Infections with the human papillomavirus tied to cervical cancer fell by more than half in U.S. teen girls after the HPV vaccine was introduced in 2006, despite high-profile controversy -- and low rates of uptake, a new study shows.
A new study shows that infections caused by the HPV human papillomavirus dropped by more than half in U.S. teens after the HPV vaccine was introduced in 2006.
The research, which was published in the June issue of The Journal of Infectious Diseases, used data from the National Health and Nutrition Examination Survey to compare the proportion of women aged 14-59 with certain types of human papillomavirus before the start of the vaccine initiative in 2006 with the prevalence of the disease after the ... (more)
The quadrivalent human papillomavirus vaccine has been provided in Australia through the National Human Papillomavirus Vaccination Program since April 2007.
Scientists may be able to predict throat cancers caused by the human papillomavirus more than 10 years before patients get diagnosed, according to research published in the Journal of Clinical Oncology.
Last month more than 1,300 women attended a health fair hosted by the Center for Prevention and Wellness in Pablo.
MICHAEL Douglas may have retracted his claim about what caused his throat cancer, but - as the mother of two red-blooded sons aged 18 and 21 - the story still triggered anxieties about the link between oral sex and this type of cancer in men.
Researchers have found that antibodies against the human papillomavirus may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.
Advaxis, Inc., , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced voting results from the Company's Annual Meeting of Stockholders, which was held in Princeton, NJ on June 14, 2013.